Erratum

This article refers to:

Retraction: Inhibition of CTCF-Regulated miRNA-185-5p Mitigates Renal Interstitial Fibrosis of Chronic Kidney Disease

In the article: Warner AW, Bienfait KL, Bledsoe M et al. Improving clinical trial sampling for future research – an international approach: outcomes and next steps from the DIA future use sampling workshop 2011. Pharmacogenomics 14(1), 103–112 (2013) (www.tandfonline.com/doi/pdf/10.2217/pgs.12.193), Table 1 was incorrectly shown as:

Table 1. Workshop participants.

Role	Name	Affiliation
Japanese workshop
Workshop chair	Amelia Wall Warner, PharmD, RPh	Head of Clinical Pharmacogenomics and Clinical Specimen Management, Merck Research Laboratories, USA
Workshop chair	Yoshiaki Uyama, PhD	The Omics Project Leader of the Pharmaceuticals and Medical Devices Agency, Japan
Presenter/panelist	Eiji Uchida, MD, PhD	Director, Clinical Trial Support Center, Showa University Hospital, Japan
Presenter/panelist	Naoyuki Kamatani, MD, PhD	Director, Center for Genomic Medicine, RIKEN Yokohama Institute, Japan
Presenter/panelist	Liou Shyh-Yuh, PhD	Director, Clinical Pharmacology, Clinical Data Science Department, Japan Development Center, Pharmaceutical Development Division, Takeda Pharmaceutical Company Limited, Japan
Presenter/panelist	Makoto Suzuki PhD	Director, Japan Disease Area Leader, Pain/Inflammation, Clinical Research, Pfizer Japan Inc., Japan
European workshop
Workshop chair	Bruno Flamion, MD, PhD	Pharmacogenomics Working Party, European Medicines Agency, Belgium
Presenter/panelist	Rob Hemmings, MSc	Committee for Medicinal Products for Human Use, European Medicines Agency, Medicines and Healthcare Products Regulatory Agency, UK
Presenter/panelist	Patrilk Kolar, PhD	Head of Unit, Personalised Medicine, Health Research Directorate, European Commission, Belgium
Presenter/panelist	Hilary M Wandall, JD, MBA, CIPP	Chief Privacy Officer, Merck, USA
Presenter/panelist	Amelia Wall Warner, PharmD, RPh	Head of Clinical Pharmacogenomics and Clinical Specimen Management, Merck Research Laboratories, USA
North American workshop
Workshop chair	Gilbert Burckart, PharmD	Associate Director, Office of Clinical Pharmacology, Office of Translational Sciences, CDER, US FDA, USA
Presenter/panelist	Ivor Pritchard, PhD	Senior Advisor to the Director, Office of Human Research Protections, US Department of Health and Human Services, USA
Presenter/panelist	Christina M Heide, JD	Office for Civil Rights, US Department of Health and Human Services, USA
Presenter/panelist	Anita J Nelsen	Director Genetics Sample Acquisition and Human Sample BioRepository, GlaxoSmithKline, USA
Presenter/panelist	Anita Pascarella-Hallett	Director, Clinical Diagnostic Services, Eli Lilly and Company, USA
Presenter/panelist	Marianna Bledsoe, MA	Senior Program Manager for Biorepositories and Biobanking, Office of Research and Development, US Department of Veterans Affairs, USA

The correct Table 1 is shown overleaf:

Table 1. Workshop participants.

Role	Name	Affiliation
Japanese workshop
Workshop chair	Amelia Wall Warner, PharmD, RPh	Head of Clinical Pharmacogenomics and Clinical Specimen Management, Merck Research Laboratories, USA
Workshop chair	Yoshiaki Uyama, PhD	The Omics Project Leader of the Pharmaceuticals and Medical Devices Agency, Japan
Presenter/panelist	Eiji Uchida, MD, PhD	Director, Clinical Trial Support Center, Showa University Hospital, Japan
Presenter/panelist	Naoyuki Kamatani, MD, PhD	Director, Center for Genomic Medicine, RIKEN Yokohama Institute, Japan
Presenter/panelist	Liou Shyh-Yuh, PhD	Director, Clinical Pharmacology, Clinical Data Science Department, Japan Development Center, Pharmaceutical Development Division, Takeda Pharmaceutical Company Limited, Japan
Presenter/panelist	Makoto Suzuki PhD	Director, Japan Disease Area Leader, Pain/Inflammation, Clinical Research, Pfizer Japan Inc., Japan
European workshop
Workshop chair	Bruno Flamion, MD, PhD	Pharmacogenomics Working Party, European Medicines Agency, Belgium
Presenter/panelist	Rob Hemmings, MSc	Committee for Medicinal Products for Human Use, European Medicines Agency, Medicines and Healthcare Products Regulatory Agency, UK
Presenter/panelist	Patrilk Kolar, PhD	Head of Unit, Personalised Medicine, Health Research Directorate, European Commission, Belgium
Presenter/panelist	Hilary M Wandall, JD, MBA, CIPP	Chief Privacy Officer, Merck, USA
Presenter/panelist	Amelia Wall Warner, PharmD, RPh	Head of Clinical Pharmacogenomics and Clinical Specimen Management, Merck Research Laboratories, USA
North American workshop
Workshop chair	Gilbert Burckart, PharmD	Associate Director, Office of Clinical Pharmacology, Office of Translational Sciences, CDER, US FDA, USA
Presenter/panelist	Ivor Pritchard, PhD	Senior Advisor to the Director, Office of Human Research Protections, US Department of Health and Human Services, USA
Presenter/panelist	Christina M Heide, JD	Office for Civil Rights, US Department of Health and Human Services, USA
Presenter/panelist	Anita J Nelsen	Director Genetics Sample Acquisition and Human Sample BioRepository, GlaxoSmithKline, USA
Presenter/panelist	Anita Pascarella-Hallett	Director, Clinical Diagnostic Services, Eli Lilly and Company, USA
Presenter/panelist	Marianna Bledsoe, MA	Senior Program Manager for Biorepositories and Biobanking, Office of Research and Development, US Department of Veterans Affairs, USA
Presenter/panelist	Barbara E Bierer, MD	Senior Vice President, Brigham and Women‘s Hospital, Professor of Medicine, Harvard Medical School, USA
Presenter/panelist	Nicole Sieffert	Program Director, Biorepository Regulatory Support, MD Anderson Cancer Center, USA

The editors of Pharmacogenomics would like to sincerely apologize for any inconvenience caused.